The medical landscape for glucose is changing, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this technique offers a simpler way to administer GLP-1 medications. These patches gradually release the medication through the epidermis offering a consistent dose of the therapeutic agent, which